Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis.
about
Non-visible asymptomatic haematuria: a review of the guidelines from the urologist's perspective.A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinomaAssessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'Haematuria work-up in general care-A German observational study.Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.Cost-effectiveness of Common Diagnostic Approaches for Evaluation of Asymptomatic Microscopic Hematuria.Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results.Multispecialty retrospective review of the clinical utility of pelvic magnetic resonance imaging in the setting of pelvic pain.
P2860
Q30238815-DBE4C268-1248-48D0-8781-38B086B01747Q35341492-4DF2E5F9-F397-4075-92AC-7B7D2E7F6550Q36073447-3B27170F-6D3E-49E2-A4EE-3A53504E4ACEQ38657216-8302742E-6BE5-4B25-8B16-E34E784544ADQ38764009-1017C970-62DE-4753-86C1-7F8DAE74727DQ38832758-02CB580B-A2AF-4BDC-AA9C-C9ACE4200B5EQ39329941-5042EC37-C724-4365-BE5C-D535A3B8EBA4Q39350373-B14DC835-943B-439B-9785-35E125527F53Q39414388-13751D42-FD9D-46A9-8F5B-443CB517B905Q48514740-536D144B-1636-4A30-A5CC-7B70BCCC325C
P2860
Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis.
@en
type
label
Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis.
@en
prefLabel
Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis.
@en
P2093
P1476
Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis.
@en
P2093
Atul B Shinagare
Esteban F Gershanik
Ramin Khorasani
Steven L Chang
Stuart G Silverman
P304
P356
10.1016/J.AMJMED.2014.02.013
P407
P577
2014-02-21T00:00:00Z